| Name | 12-Iminodaunorubicin HCl |
|---|---|
| Synonyms |
5-iminodaunorubicin hydrochloride
aromatic/heteroaromatic sulfonamide 14 5-Imino-4-methyl-4,5-dihydro-[1,3,4]thiadiazol-2-sulfonsaeure-amid 5-imino-4-methyl-4,5-dihydro-[1,3,4]thiadiazole-2-sulfonic acid amide 5-iminodaunomycin hydrochloride 1,3,4-Thiadiazole-2-sulfonamide,4,5-dihydro-5-imino-4-methyl |
| Description | 5-Iminodaunorubicin hydrochloride is a quinone-modified anthracycline that retains antitumor activity[1]. 5-Iminodaunorubicin hydrochloride produces protein-concealed DNA strand breaks in cancer cells[2]. |
|---|---|
| Related Catalog | |
| In Vitro | In mouse leukemia L1210 cells, 5-Iminodaunorubicin produces protein-concealed DNA strand breaks. Many of the 5-iminodaunorubicin breaks may arise from apposed single-strand breaks (i.e., double-strand breaks)[2]. |
| In Vivo | In rat, 5-Iminodaunorubicin (5-ID; 1-16 mg/kg) treatment produces widening of the QRS complex, increased R- and S-wave voltage, and prolonged the Q alpha T interval. And the quinone redox cycling is suppressed in 5-Iminodaunorubicin. 5-Iminodaunorubicin shows lower cardiotoxic[1]. |
| References |
| Density | 1.51g/cm3 |
|---|---|
| Boiling Point | 864.9ºC at 760 mmHg |
| Molecular Formula | C27H31ClN2O9 |
| Molecular Weight | 562.99600 |
| Flash Point | 476.9ºC |
| Exact Mass | 562.17200 |
| PSA | 192.62000 |
| LogP | 2.81610 |
| Index of Refraction | 1.698 |